Delivery Order SPE2DB24D1201-SPE2DB25FJCTD
Award Date
5/19/25
Potential Completion Date
5/20/25
Potential Value
$3K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award, valued at $6,153.07, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a delivery order for the medication VEMLIDY 25 MG TABLET UU 30S, with an ultimate completion date of April 16, 2025. The contract is not set aside and is a firm fixed-price type. Amerisourcebergen Drug Corp is the prime contractor, and this award is associated with a larger...
This federal contract award, valued at $8,773.04, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order (DO) for 4,568,012,993 units of the medication VEMLIDY 25 MG TABLET. It has a firm fixed price and an ultimate completion date of April 24, 2025. The contract is not designated as a set-aside. Amerisourcebergen Drug Corp holds a significant $999,999,999.00...
This federal contract award, valued at $5,656.80, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a delivery order for the medication VEMLIDY 25 MG TABLET UU 30S, with a performance period ending on April 30, 2025. The contract is a firm fixed-price, non-set-aside award, indicating open competition. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract...
The federal contract award is for the delivery of VEMLIDY 25 MG TABLET UU 30S, a pharmaceutical product, to the Defense Logistics Agency (DLA). The contract was awarded to the prime contractor Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order with a Firm Fixed Price of $2,828.40 and an Ultimate Completion Date of January 23, 2025. The contract was awarded on January 22, 2025 and does not have a set-aside...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $5,130.52 firm fixed price delivery order is for the supply of VEMLIDY 25 MG TABLET medication. The contract has an ultimate completion date of February 24, 2025 and was awarded on February 21, 2025. This award is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) between Amerisourcebergen and the...
This federal contract award is for the delivery of VEMLIDY 25 MG TABLET UU 30S, a pharmaceutical product, to the Medical Supply Chain division of the Defense Logistics Agency (DLA). The contract, valued at $12,904.04, was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order with a Firm Fixed Price pricing type and has an ultimate completion date of April 4, 2025. No set-aside designation was used for this...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $3,771.31 firm-fixed-price delivery order is for the supply of VEMLIDY 25 MG TABLET UU 30S, with a completion date of May 14, 2025. The contract is not set-aside. Amerisourcebergen Drug Corp holds a substantial Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999.00, which...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $4,431.77 firm fixed-price delivery order is for the medication VEMLIDY 25 MG TABLET, with a period of performance through April 2025. The contract is not set aside for any specific business category. AmerisourceBergen Drug Corp holds a substantial Indefinite Delivery Contract (IDC) with DLA Troop Support Medical,...
This federal contract award is for the delivery of VEMLIDY 25 MG TABLET UU 30S to the Defense Logistics Agency (DLA), a major defense agency. The $3,441.74 fixed-price contract was awarded to Amerisourcebergen Drug Corp, a for-profit pharmaceutical distributor and healthcare solutions provider, on December 9, 2024, with a completion date of December 10, 2024. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary...
This federal contract award from the Defense Logistics Agency (DLA) was issued to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $19,301.43 firm fixed-price delivery order contract is for the supply of VEMLIDY 25 MG TABLET, a medication used in the treatment of certain medical conditions. The contract has an ultimate completion date of November 14, 2024 and was awarded on November 13, 2024. This award is associated with a larger...